Immune response more complicated than thought

NewsGuard 100/100 Score

By Piriya Mahendra, medwireNews Reporter

Researchers have found that the orientation and concentration of antibodies could determine the control of bacterial infection.

It has been known since the 1960s that antibodies bind to the bacterial surface via the fragment crystallizable (Fc) region, explain Pontus Nordenfelt (Harvard Medical School, Boston, Massachusetts, USA) and team in the Journal of Experimental Medicine.

However, they have, for the first time, shown that antibodies bind to the streptococcal bacterial surface via the fragment antigen-binding (Fab) region in serious and life-threatening infections such as sepsis and necrotizing fasciitis.

"This information is important and fundamental to improving our understanding of streptococcal infections, but our results also show that the principle described could apply to many different types of bacteria," commented Nordenfelt in a press statement.

The team found that the concentration of antibodies in the local environment of the body controls how the antibodies bind to bacterial surfaces.

In the throat, where the concentration of antibodies is low, the antibodies bind via Fc and are protected against phagocytic killing .

However, in the blood, where immunoglobulin (Ig)G concentration is high, the antibodies bind to the bacteria via Fab, allowing opsonization and bacterial killing, the researchers explain.

"IgG-poor environments represent the natural habitat for IgGFc-binding bacteria. And IgGFc-binding proteins may have evolved to execute their function in such environments."

They say the lack of bacterial protection against phagocytosis in plasma explains why severe infections are rare in comparison to more common and often milder cases of streptococcal throat and skin infections.

The findings come from an analysis of samples from a patient with invasive Streptococcus pyogenes infection.

Co-author Lars Björck (Lund University, Sweden) remarked: "It is fantastic to have been involved in moving a major step closer to understanding the biological and medical importance of these proteins together with talented young colleagues."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New influenza vaccine strategies aim to enhance protection with T-cell responses